Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
This study is currently recruiting participants.
Study NCT00450086 Information provided by Dr. Falk Pharma GmbH
First Received: March 20, 2007 Last Updated: July 24, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Collagenous Colitis
Additional conditions recognized in this trial
Colitis
Colitis, Collagenous
More general conditions related to this trial
Colitis, Microscopic
Colonic Diseases
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Intestinal Diseases
Interventions listed in this trial
Budesonide
Mesalazine
Placebo
Additional drug interventions recognized in this trial
Mesalamine
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Autonomic Agents
Bronchodilator Agents
Central Nervous System Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Dr. Falk Pharma GmbH
Back to top of Main Content
